[PDF][PDF] Cell volume measurement using scanning ion conductance microscopy

…, EV Sviderskaya, CL Johnston, CR Coombes… - Biophysical journal, 2000 - cell.com
We report a novel scanning ion conductance microscopy (SICM) technique for assessing
the volume of living cells, which allows quantitative, high-resolution characterization of …

Mammosphere formation assay from human breast cancer tissues and cell lines

Y Lombardo, A de Giorgio, CR Coombes… - JoVE (Journal of …, 2015 - jove.com
Similar to healthy tissues, many blood and solid malignancies are now thought to be organised
hierarchically, with a subset of stem-like cancer cells that self-renew while giving rise to …

Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2 …

…, R Di Marsico, C Tondini, S Gori, CR Coombes… - Breast cancer research …, 2012 - Springer
This multicenter phase II trial was designed to evaluate the activity of lapatinib in metastatic
breast cancer patients with HER2-negative primary tumors and HER2-positive circulating …

The role of SRC-3 in human breast cancer

…, M Gudi, K Hogben, S Sousha, CR Coombes… - Nature reviews Clinical …, 2010 - nature.com
Members of the nuclear receptor superfamily are ligand-regulated transcription factors
involved in the control of a broad range of normal physiological and disease processes. The …

Multicenter reproducibility of 18F-fluciclatide PET imaging in subjects with solid tumors

…, MP Miller, EJ Somer, CR Coombes… - Journal of Nuclear …, 2015 - Soc Nuclear Med
Integrins are upregulated on both tumor cells and associated vasculature, where they play
an important role in angiogenesis and metastasis. Fluciclatide is an arginine-glycine-aspartic …

[HTML][HTML] Evaluation of limited blood sampling population input approaches for kinetic quantification of [18F]fluorothymidine PET data

KB Contractor, LM Kenny, CR Coombes… - EJNMMI research, 2012 - Springer
Background Quantification of kinetic parameters of positron emission tomography (PET)
imaging agents normally requires collecting arterial blood samples which is inconvenient for …

Fulvestrant in advanced breast cancer following tamoxifen and aromatase inhibition: a single center experience

J Wang, S Jain, CR Coombes, C Palmieri - The breast journal, 2009 - Wiley Online Library
Fulvestrant is a pure estrogen receptor (ER) antagonist with no agonist effects. We describe
the experience of a single center involving 45 postmenopausal women with advanced …

[PDF][PDF] The ethnic profile of triple-negative breast cancer

…, C Palmieri, CR Coombes - Oncology Research and …, 2008 - scholar.archive.org
Accessible online at: www. karger. com/onk Fax+ 49 761 4 52 07 14 Information@ Karger. de
www. karger. com breast feed, younger age at first full-term pregnancy, use of medications …

ONLINE ONLY: Breast cancer metastasizing to the tongue

…, L Panchal, G Sandhu, CR Coombes… - … Journal of Surgery, 2008 - search.proquest.com
A 24-year-old woman presented with a lump in the right breast. A right mastectomy and
axillary clearance with immediate reconstruction was performed. The operative specimen …

4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer

RC Coombes, M Dowsett, P Goss, JC Gazet, A Brodie - The Lancet, 1984 - Elsevier
4-hydroxyandrostenedione, a potent inhibitor of the aromatase (oestrogen synthetase)
system, was given to 11 patients with metastatic breast cancer. After a single 500 mg …